Using the LTEM assay as an in vitro cell model, we further confirmed that S100A6 promoted B cells to penetrate BBB endothelial layer, causing the phenomenon similar to the in vivo observations in AE patients. This evidence concerns the gene S100A6 and acrodermatitis enteropathica.